Robert Ortenzio - Select Medical Executive Chairman of the Board, Co-Founder
| SEM Stock | USD 27.06 0.63 2.38% |
Chairman
Mr. Robert A. Ortenzio is Executive Chairman of the Board, CoFounder of the Company. Mr. Ortenzio served as our Executive Chairman and CoFounder since January 1, 2014. Mr. Ortenzio served as our Chief Executive Officer from January 1, 2005 until December 31, 2013, and Mr. Ortenzio served as our President and Chief Executive Officer from September 2001 to January 1, 2005. Mr. Ortenzio also served as our President and Chief Operating Officer from February 1997 to September 2001. Mr. Ortenzio cofounded the Company and has served as a director since February 1997. Mr. Ortenzio also serves on the board of directors of Concentra Group Holdings Parent. He was an Executive Vice President and a director of HorizonCMS Healthcare Corporation from July 1995 until July 1996. In 1986, Mr. Ortenzio cofounded Continental Medical Systems, Inc., serving in a number of different capacities, including as a Senior Vice President from February 1986 until April 1988, as Chief Operating Officer from April 1988 until July 1995, as President from May 1989 until August 1996, and as Chief Executive Officer from July 1995 until August 1996. Before cofounding Continental Medical Systems, Inc., he was a Vice President of Rehab Hospital Services Corporationrationration. Mr. Ortenzio is the son of Rocco A. Ortenzio, our Vice Chairman and CoFounder. since 2014.
| Age | 66 |
| Tenure | 10 years |
| Address | 4714 Gettysburg Road, Mechanicsburg, PA, United States, 17055 |
| Phone | 717 972 1100 |
| Web | https://www.selectmedical.com |
Robert Ortenzio Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Ortenzio against Select Medical stock is an integral part of due diligence when investing in Select Medical. Robert Ortenzio insider activity provides valuable insight into whether Select Medical is net buyers or sellers over its current business cycle. Note, Select Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Select Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Ortenzio over a week ago Disposition of 50000 shares by Robert Ortenzio of Select Medical at 29.9 subject to Rule 16b-3 |
Select Medical Management Efficiency
The company has Return on Asset of 0.0452 % which means that on every $100 spent on assets, it made $0.0452 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2022 %, implying that it generated $0.2022 on every 100 dollars invested. Select Medical's management efficiency ratios could be used to measure how well Select Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Select Medical's Return On Capital Employed is very stable compared to the past year. As of the 20th of April 2024, Return On Equity is likely to grow to 0.20, while Return On Tangible Assets are likely to drop 0.06. At this time, Select Medical's Asset Turnover is very stable compared to the past year.Similar Executives
| Found 5 records | CHAIRMAN Age | ||
| Walter Woltosz | Simulations Plus | 70 | |
| Jonathan Phillips | Streamline Health Solutions | 44 | |
| Wyche III | Streamline Health Solutions | 52 | |
| Robert Frist | HealthStream | 57 | |
| Frank Williams | Evolent Health | 58 | |
Management Performance
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0452 |
Select Medical Holdings Leadership Team
Elected by the shareholders, the Select Medical's board of directors comprises two types of representatives: Select Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Select. The board's role is to monitor Select Medical's management team and ensure that shareholders' interests are well served. Select Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Select Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Saich, Executive Vice President Chief Human Resources Officer | ||
| Bridget Sherick, Senior Services | ||
| James Ely, Independent Director | ||
| James Dalton, Independent Director | ||
| Michael Malatesta, Executive CFO | ||
| Russell Carson, Lead Independent Director | ||
| Bryan Cressey, Independent Director | ||
| Thomas Scully, Independent Director | ||
| William Frist, Independent Director | ||
| Martin Jackson, Chief Financial Officer, Executive Vice President | ||
| Thomas Mullin, Executive Vice President - Hospital Operations | ||
| Leopold Swergold, Independent Director | ||
| Katherine Davisson, Independent Director | ||
| Shelly Eckenroth, Marketing Communications | ||
| David Chernow, President, Chief Executive Officer | ||
| Christopher Weigl, Controller VP | ||
| Robert Breighner, Vice President, Compliance and Audit Services and Corporate Compliance Officer | ||
| Parvinderjit Khanuja, Independent Director | ||
| Michael Tarvin, Executive Vice President General Counsel, Secretary | ||
| John Duggan, Executive Counsel | ||
| Rocco Ortenzio, Vice Chairman of the Board, Co-Founder | ||
| Daniel Thomas, Independent Director | ||
| Mary Lacey, Senior Officer | ||
| Scott Romberger, Senior Vice President, Chief Accounting Officer, Controller | ||
| Robert Ortenzio, Executive Chairman of the Board, Co-Founder | ||
| Brian Rusignuolo, Executive Officer | ||
| Joel Veit, VP Treasurer | ||
| Marilyn Tavenner, Independent Director | ||
| Harold Paz, Independent Director |
Select Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Select Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0452 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 8.49 B | ||||
| Shares Outstanding | 128.36 M | ||||
| Shares Owned By Insiders | 17.27 % | ||||
| Shares Owned By Institutions | 78.57 % | ||||
| Number Of Shares Shorted | 2.22 M | ||||
| Price To Earning | 13.33 X |
Currently Active Assets on Macroaxis
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Select Medical Holdings information on this page should be used as a complementary analysis to other Select Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Select Stock analysis
When running Select Medical's price analysis, check to measure Select Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Select Medical is operating at the current time. Most of Select Medical's value examination focuses on studying past and present price action to predict the probability of Select Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Select Medical's price. Additionally, you may evaluate how the addition of Select Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Select Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.668 | Dividend Share 0.5 | Earnings Share 1.91 | Revenue Per Share 54.133 | Quarterly Revenue Growth 0.049 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.